 | • レポートコード：MRC2202A105 • 出版社/出版日：Mordor Intelligence / 2022年1月28日 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Team User | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の自動体外式除細動器（AED）市場規模が2020年601.34百万ドルから2026年1,126.02百万ドルに達し、年平均9.43％成長すると予測しています。本調査レポートでは、自動体外式除細動器（AED）の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場インサイト、分析種類別（半自動型体外式除細動器、全自動型体外式除細動器）分析、エンドユーザー別（病院/クリニック、在宅医療、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場インサイト ・世界の自動体外式除細動器（AED）市場規模：分析種類別（半自動型体外式除細動器、全自動型体外式除細動器） ・世界の自動体外式除細動器（AED）市場規模：エンドユーザー別（病院/クリニック、在宅医療、その他） ・世界の自動体外式除細動器（AED）市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Asahi Kasei Corporation、Koninklijke Philips NV、Nihon Kohden Corporation、Schiller AG、Shenzhen Mindray Bio-Medical Electronics Co. Ltd、Stryker Corporation、CU Medical System Inc.、Mediana Co. Ltd、BPL Medical Technologies Pvt. Ltd、ViVest Medical） ・市場機会・将来傾向 |
The global automated external defibrillator market was valued at USD 601.34 million in 2020 and is projected to be worth USD 1126.02 million by 2026, registering a CAGR of 9.43% during the forecast period of 2021-2026. The automated external defibrillators are life-saving devices that help in the correction of cardiac rhythm. The major factors driving the growth of the automated electronic defibrillator market include the growing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in the field supported by the increasing investment by the market players.
Key Highlights
- The burden of cardiac diseases is rising with the prevailing sedentary lifestyle in the population and the growing geriatric population around the world. For instance, the Journal of Cardiovascular Development and Disease article titled ‘’Cardiovascular Risks Associated with Gender, and Aging’’ published in April 2019, reported that The aging and elderly population are particularly susceptible to cardiovascular diseases.
- Additionally, it also reported that risk factors closely associated with advanced age, such as frailty, obesity, and diabetes, have been shown to compound risks of cardiovascular disease. Such studies demonstrate that the chances of Cardiovascular diseases increase with age.
- Furthermore, according to the Australian Government, Australia Institute of Health and Welfare article titled ‘‘Heart, stroke and vascular disease—Australian facts’’ updated in September 2021 reported that in the year 2019, cardiovascular diseases was the underlying cause of death in Australia and accounts 42,300 deaths which are nearly 25% of all deaths in Australia. Such a high burden of deaths generates a need for automated external defibrillators, thus driving the growth of the market.
- Moreover, the technological advancement in the field and the launch of new products by the market players boost the growth of the market. For instance, in July 2020, ZOLL Medical Corporation (Asahi Kasei Group company) launched its new remote view technology on the X Series monitor/defibrillator developed for EMS agencies.
- Thus, the automated external defibrillators market is expected to show lucrative growth over the forecast period. However, the factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the studied market over the forecast period.
Key Market Trends
The Rising Prevalence of Cardiac Diseases to Drive the Market
- The rising prevalence of cardiac diseases across different age groups due to stressful work conditions, sedentary lifestyle growing consumption of tobacco, alcohol, and substance abuse is driving the growth of the automated external defibrillator market over the forecast period.
- According to the International Journal of Stroke article titled ‘‘Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge’’ published in January 2020 reported that the worldwide prevalence of atrial fibrillation is 37,574 million cases (0.51% of worldwide population), also increased by 33% during the last 20 years. It also reported that future projections suggest that the absolute atrial fibrillation burden may increase by more than 60% in 2050. Such a growing burden of arrhythmia creates demand for the automated external defibrillator and thus drives the growth of the studied market over the forecast period.
- According to the Australian Government, Australia Institute of Health and Welfare article titled ‘’Heart, stroke and vascular disease—Australian facts’’ updated in September 2021 reported that in 2018-19 there were 5,91,000 hospitalizations with cardiovascular diseases as principal diagnosis happens in Australia. Such a high number of hospitalization due to cardiovascular diseases generates a need for the devices o correct cardiac rhythm, and thus it is expected to drive the growth of the market.
- Furthermore, the increasing number of deaths due to cardiac diseases is also boosting the growth of the market. For instance, according to the World Health Organization (WHO)’s article titled ‘’Cardiovascular diseases (CVDs)’’ published in June 2021 reported that cardiovascular diseases are the leading cause of death globally. Additionally, it also reports that an estimated 17.9 million people died from CVDs in 2019, which represents 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Such a high number of deaths due to it creates demand for the devices that helps in cardiac rhythm corrections and drive the growth of the market.
- Also, Journal of Cardiovascular Development and Disease article titled ‘‘Cardiovascular Risks Associated with Gender and Aging’’ published in April 2019 reported that American Heart Association (AHA) 2019 Heart Disease and Stroke Statistical Update, the incidence of cardiovascular diseases from age 60–79 years was reported to be 77.2% in males and 78.2% in females. Furthermore, the incidence of CVD in adults above 80 years of age was reported to be 89.3% in males and 91.8% in females. Such a high prevalence of cardiac disease in older age is driving the growth of the market. Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period.
North America is Expected to Hold a Major Market Share
- The US automated external defibrillators market is expected to grow during the forecast period due to the high burden and increasing prevalence of cardiovascular diseases in the country, the launch of new products, and key market players in the region. For instance, according to the American Heart Association statistics published in January 2019, nearly half of the Americans have some cardiovascular diseases, including hypertension, coronary heart diseases, etc., which is expected to increase the burden of cardiovascular diseases in the country, driving the growth of the studied market.
- According to the American Heart Association, over 350,000 out-of-hospital cardiac arrests occur in the United States each year, with more than 100,000 happening outside the country. Less than half (45.7%) of cardiac arrest victims get immediate help before emergency responders arrive in part because emergency medical services take, on average, between four and ten minutes to reach someone in cardiac arrest. However, if AEDs are available nearby, this high mortality from out-of-hospital cardiac arrests can be reduced, which may increase the demand for AEDs in the country. Thus, the studied market is expected to grow.
- Further, as per the September 2021 report of the Centers for Disease Control and Prevention, about 659,000 people in the United States die from heart diseases every year, and approximately 805,000 people have a heart attack every year, of which 605,000 experienced their first heart attack, and 200,000 people already had one heart attack. This high prevalence of heart attack is expected to fuel the growth of the market studied in the United States.
- The rising prevalence of cardiovascular diseases in Canada, increasing research and development investment, and rising awareness about defibrillators in the country are expected to boost the growth of the automated external defibrillators market over the forecast period. According to the Canadian Centre for Occupational Health and Safety (CCOHS) article published in June 2020, in Canada, more than 40,000 people die of sudden cardiac arrest, which is about one person every 12 minutes, and over 100 people per day. This high number of sudden cardiac arrests in the country leads to high demand for automated external defibrillators (AEDs), which can be crucial in preventing these deaths. Thus, the market is expected to grow over the forecast period.
- As per the source mentioned above, many other medical conditions and lifestyles can put people at higher risk of heart diseases, including diabetes, overweight and obesity, unhealthy diet, high alcohol consumption, and physical inactivity.
Competitive Landscape
The Automated External Defibrillator Market is moderately competitive, with the presence of a few major players like Asahi Kasei Corporation, Schiller AG, Stryker Corporation, Mediana Co. Ltd, etc. However, with technological advancements and product innovation, the market players are introducing new products with cost-effective pricing.
- September 2021 – Shenzhen Mindray Bio-Medical Electronics Co. Ltd completed its acquisition of HyTest Invest Oy and its subsidiaries, which enables the company to have top-notch raw material R&D and innovation capabilities. To maintain its position as a global leader in the upstream in vitro diagnostic raw material business, the company can invest in R&D, as well as reinforce and improve its major competitive advantage.
- September 2021 – Stryker Corporation partnered with Unites States Lacrosse to serve as the Official AED provider of United States Lacrosse and the United States National Teams. As part of this partnership, United States Lacrosse members receive discounted pricing on Stryker AED devices.
- April 2021 – ViVest Medical announced that its wearable electrocardiographic defibrillator (WCD). ViVestMedical wearable ECG defibrillators are expected to become the first made-in-China product on the market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSUGHTS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cardiovascular Diseases
4.2.2 Technological Advancements in the Field of Defibrillators
4.2.3 Increasing Investments by Private Players
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Lack of Awareness and Early Corrective Measures about Sudden Cardiac Arrest (SAC)
4.4 Industry Attractiveness – Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
4.5 The Impact of COVID-19 on the Market
5 MARKET SEGMENTATION
5.1 Analysis Type
5.1.1 Semi-automated External Defibrillators
5.1.2 Fully-automated External Defibrillators
5.2 End-User
5.2.1 Hospitals/Clinics
5.2.2 Home Care
5.2.3 Other End-Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Asahi Kasei Corporation
6.1.2 Koninklijke Philips NV
6.1.3 Nihon Kohden Corporation
6.1.4 Schiller AG
6.1.5 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
6.1.6 Stryker Corporation
6.1.7 CU Medical System Inc.
6.1.8 Mediana Co. Ltd
6.1.9 BPL Medical Technologies Pvt. Ltd
6.1.10 ViVest Medical
7 MARKET OPPORTUNITIES AND FUTURE TRENDS